Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
ESMO Open|January 28, 2025
Is pathological response an adequate surrogate marker for survival in neoadjuvant therapy with immune checkpoint inhibitors?K Sugiyama, A Gordon, S Popat, et al.
British Journal of Cancer|August 18, 2005
Second primary malignancies after treatment for malignant lymphomaA Okines, C S Thomson, C R Radstone, et al.
British Journal of Cancer|October 1, 2009
Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trialA Okines, O Del Puerto, D Cunningham, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
UK real-world evidence on pembrolizumab and neoadjuvant chemotherapy for early-stage triple-negative breast cancerJ McKeon, E Daniels, A Halstead, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 10, 2014
Febrile neutropaenia and chemotherapy discontinuation in women aged 70 years or older receiving adjuvant chemotherapy for early breast cancerD Adjogatse, E Thanopoulou, A Okines, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 14, 2016
The Impact of Systemic Therapy Beyond First-line Treatment for Advanced Cervical CancerJ McLachlan, S Boussios, A Okines, et al.
British Journal of Cancer|May 14, 2009
A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinomaN Starling, A Okines, D Cunningham, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 14, 2022
A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast CancerA Lerner, K Keshwani, A Okines, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 26, 2021
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysisG Curigliano, V Mueller, V Borges, et al.
ESMO Open|August 31, 2024
Association of post-operative ctDNA detection with outcomes of patients with early breast cancersR Cutts, L Ulrich, M Beaney, et al.
Pageof 1